Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Autism Research : Official Journal of the International Society for Autism Research
|
October 27, 2015
Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity
Chai K Lim, Musthafa M Essa, Roberta de Paula Martins, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 3, 2020
A Robust Intrinsically Green Fluorescent Poly(Amidoamine) Dendrimer for Imaging and Traceable Central Nervous System Delivery in Zebrafish
Guoying Wang, Xiaowei Zhao, Haigang Wu, et al.
British Journal of Pharmacology
|
November 7, 2012
Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo
S J Ford, P Obeidy, D B Lovejoy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 10, 2026
Potential regulation of kynurenine pathway metabolism by the galantamine-memantine combination in rheumatologic diseases: A hypothesis-driven review
Navya Mathew, Sebin George, Patricia Rejimon, et al.
Scientific Reports
|
May 24, 2018
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
Pratishtha Chatterjee, Kathryn Goozee, Chai K Lim, et al.
Journal of Alzheimer'S Disease : JAD
|
June 16, 2020
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load
Pratishtha Chatterjee, Maryam Mohammadi, Kathryn Goozee, et al.
Journal of Neuroinflammation
|
October 12, 2019
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease
Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, et al.
Brain Sciences
|
January 8, 2025
Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia
Emma D Frost, Swanny X Shi, Vishnu V Byroju, et al.
Neurobiology of Disease
|
June 8, 2022
Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β
Marcela Cespedes, Kelly R Jacobs, Paul Maruff, et al.
Journal of Medicinal Chemistry
|
December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis
H N Bramson, J Corona, S T Davis, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Autism Research : Official Journal of the International Society for Autism Research
|
October 27, 2015
Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity
Chai K Lim, Musthafa M Essa, Roberta de Paula Martins, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 3, 2020
A Robust Intrinsically Green Fluorescent Poly(Amidoamine) Dendrimer for Imaging and Traceable Central Nervous System Delivery in Zebrafish
Guoying Wang, Xiaowei Zhao, Haigang Wu, et al.
British Journal of Pharmacology
|
November 7, 2012
Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo
S J Ford, P Obeidy, D B Lovejoy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 10, 2026
Potential regulation of kynurenine pathway metabolism by the galantamine-memantine combination in rheumatologic diseases: A hypothesis-driven review
Navya Mathew, Sebin George, Patricia Rejimon, et al.
Scientific Reports
|
May 24, 2018
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
Pratishtha Chatterjee, Kathryn Goozee, Chai K Lim, et al.
Journal of Alzheimer'S Disease : JAD
|
June 16, 2020
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load
Pratishtha Chatterjee, Maryam Mohammadi, Kathryn Goozee, et al.
Journal of Neuroinflammation
|
October 12, 2019
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease
Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, et al.
Brain Sciences
|
January 8, 2025
Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia
Emma D Frost, Swanny X Shi, Vishnu V Byroju, et al.
Neurobiology of Disease
|
June 8, 2022
Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β
Marcela Cespedes, Kelly R Jacobs, Paul Maruff, et al.
Journal of Medicinal Chemistry
|
December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis
H N Bramson, J Corona, S T Davis, et al.
Page
of 8